350-32-3

Basic information

• Product Name: 2-Fluoro-4-nitro-benzamide
• Synonyms: 2-Fluoro-4-nitro-benzamide
• CAS NO: 350-32-3
• Molecular Formula: C₇H₅FN₂O₃
• Molecular Weight: 184.13
• Mol File: 350-32-3.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 317.61°C at 760 mmHg
• Flash Point: 145.885°C
• Appearance: /
• Density: 1.483g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.587
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-Fluoro-4-nitro-benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Fluoro-4-nitro-benzamide(350-32-3)
• EPA Substance Registry System: 2-Fluoro-4-nitro-benzamide(350-32-3)

Safety Data

• Hazardous Substances Data: 350-32-3(Hazardous Substances Data)

Usage

Uses

2-Fluoro-4-nitrobenzamide

InChI:InChI=1/C7H5FN2O3/c8-6-3-4(10(12)13)1-2-5(6)7(9)11/h1-3H,(H2,9,11)

Upstream product

• 403-23-6 2-fluoro-4-nitrobenzoyl chloride 
• 403-24-7 2-fluoro-4-nitrobenzoic acid 
• 1427-07-2 2-fluoro-4-nitrotoluene 

Downstream Products

• 34667-88-4 2-fluoro-4-nitrobenzonitrile 
• 53312-80-4 4-amino-2-fluorobenzonitrile 
• 380241-60-1 4-amino-2-fluoro-5-iodobenzonitrile 
• 380241-69-0 (4-cyano-2-iodo-5-fluorophenyl)carbamic acid tert-butyl ester 
• 380241-81-6 6-fluoro-2-[2-[(2-methoxyethoxy)methoxy]biphenyl-3-yl]-1H-indole-5-carbonitrile 
• 35212-90-9 methyl 3-amino-6-nitro<1>benzothiophene-2-carboxylate 
• 609783-45-1 4-amino-2-fluorobenzamide 

Relevant articles and documents

Benzothiazole compounds and medical application

The invention discloses a benzothiazole compound and medical application thereof, particularly relates to a benzothiazole compound shown as a formula I and medical application thereof, and especiallyrelates to application of the benzothiazole compound serving as a USP7C-terminal structural domain regulating agent in medicines for preventing and treating myelodysplastic syndromes and malignant tumors. The benzothiazole compound shown in the formula I or the pharmaceutically acceptable salt or solvate of the benzothiazole compound has strong binding force with USP7C-terminal protein; and the protein level of DNMT1 in tumor cells can be reduced, so that the compound can be applied to the preparation of USP7 regulators, has a remarkable anti-tumor cell proliferation effect, and can be used for preparing medicines for preventing or treating myelodysplastic syndrome and malignant tumors.

SUBSTITUTED OXOPYRIDINE DERIVATIVES

The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and o edemas, and also ophthalmic disorders.

FACTOR XIA-INHIBITING PYRIDOBENZAZEPINE AND PYRIDOBENZAZOCINE DERIVATIVES

The invention relates to substituted pyridobenzazepine and pyridobenzazocine derivatives and to processes for preparation thereof, and also to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.